| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/21/2011 | WO2011046454A1 Treatment of molluscum contagiosum using honey |
| 04/21/2011 | WO2011046258A1 Pharmacological composition whereby statin and coq10 compounds are enhanced |
| 04/21/2011 | WO2011045764A1 A product for delivering antimicrobially active substances to an infected site |
| 04/21/2011 | WO2011045471A1 Compositions and methods and uses related thereto |
| 04/21/2011 | WO2011045427A1 Use of extract of leeches as anti-bacterial agent |
| 04/21/2011 | WO2011044934A1 Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof |
| 04/21/2011 | WO2011044628A1 Allergy treatment using acid treated aqueous whey protein extract |
| 04/21/2011 | WO2011018080A3 Composition having strains of lactobacillus fermentum |
| 04/21/2011 | WO2011011725A3 Use of toxoplasma and derived compositions to prevent or treat microbial infections |
| 04/21/2011 | WO2010138180A3 Compositions and methods for cardiac tissue repair |
| 04/21/2011 | WO2010067199A3 Mixtures of plants in spagyric mother tincture for dry cough in babies |
| 04/21/2011 | WO2010025859A3 Stabilization of cells by ionic liquids |
| 04/21/2011 | WO2008090472A3 Tissue progenitor cells that overexpress erg |
| 04/21/2011 | US20110093020 Poly-porous hollow screw for target delivery of growth factors and stem cells:the design and potential clinical application |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091569 Echinoderm-derived extracts, methods of preparation and uses thereof |
| 04/21/2011 | US20110091568 Media conditioned by stem cells and uses therefor |
| 04/21/2011 | US20110091567 Tissue organizing structure and therapeutic methods |
| 04/21/2011 | US20110091550 Methods for Promoting the Revascularization and Reenervation of CNS Lesions |
| 04/21/2011 | US20110091517 Biocompatible scaffolds with tissue fragments |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091448 Methods for regulation of stem cells |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091433 Treatment using reprogrammed mature adult cells |
| 04/21/2011 | US20110091432 Isolated pediococcus acidilactici 05b0111 and method of producing exopolysaccharide |
| 04/21/2011 | US20110091431 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
| 04/21/2011 | US20110091430 Mesenchymal stem cells and methods of use thereof |
| 04/21/2011 | US20110091429 Methods for Enhancing Stem Cell Engraftment During Transplantation |
| 04/21/2011 | US20110091428 Compositions of adult organ stem cells and uses thereof |
| 04/21/2011 | US20110091427 Methods for treating a kidney injury |
| 04/21/2011 | US20110091426 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells |
| 04/21/2011 | US20110091424 Oral dosage composition |
| 04/21/2011 | US20110091412 Mutant interleukin-2 (il-2) polypeptides |
| 04/21/2011 | US20110091406 Composition and method for protecting labile active components during high temperature drying |
| 04/21/2011 | US20110091375 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 04/21/2011 | CA2777783A1 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
| 04/21/2011 | CA2777718A1 Closed system separation of adherent bone marrow stem cells for regenerative medicine applications |
| 04/21/2011 | CA2777692A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | CA2777663A1 Method for treating chronic nerve tissue injury using a cell therapy strategy |
| 04/21/2011 | CA2777595A1 Allergy treatment using acid treated aqueous whey protein extract |
| 04/21/2011 | CA2777401A1 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | CA2776868A1 Compositions and methods and uses related thereto |
| 04/20/2011 | EP2311958A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311938A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311499A1 Telomelysin-GFP gene-containing recombinant virus |
| 04/20/2011 | EP2311495A1 Vascularization inhibitors |
| 04/20/2011 | EP2311473A1 Lactobacillus plantarum strains as probiotics |
| 04/20/2011 | EP2311472A1 Cognitive disorder-ameliorating agent |
| 04/20/2011 | EP2311471A2 Regeneration and augmentation of bone using mesenchymal stem cells |
| 04/20/2011 | EP2311470A1 Method for simultaneous induction of ctl and t cell |
| 04/20/2011 | EP2311469A2 Methods and compositions for tissue regeneration |
| 04/20/2011 | EP2310039A1 Fgf-9 and its use relating to blood vessels |
| 04/20/2011 | EP2309870A2 Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product |
| 04/20/2011 | EP1938774B1 Medical artificial nerve graft containing silk fibroin and its preparation method |
| 04/20/2011 | EP1784200B1 Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| 04/20/2011 | CN201798932U Formula bag for treating lumbar disc protrusion |
| 04/20/2011 | CN201798927U Orally-taken particulate used for female health-protection |
| 04/20/2011 | CN201798926U Oral granule capable of protecting livers |
| 04/20/2011 | CN1977938B Bone-invigorating health carefood with effective calcium supplementation and its preparing method |
| 04/20/2011 | CN1930282B Novel lactic acid bacterium |
| 04/20/2011 | CN1901896B Use of selected amino acid-zinc complexes as anti-malarials |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1795265B Control of stem cell differentiation induction and differentiation potency |
| 04/20/2011 | CN1594556B Bone marrow mononuclear cell infected by recombinant co-gene adeno-associated virus and use thereof |
| 04/20/2011 | CN102027107A Reducing conjugative plasmids in bacteria |
| 04/20/2011 | CN102027106A Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations |
| 04/20/2011 | CN102026645A Oncolytic rhabdovirus |
| 04/20/2011 | CN102026644A Controlled activation of the reuterin-production machinery of lactobacillus reuteri |
| 04/20/2011 | CN102021194A Activation factor for improving bacteria gene expression |
| 04/20/2011 | CN102021162A High-activity bifidobacterium powder and preparation method thereof |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102019031A Health preserving pad |
| 04/20/2011 | CN102018954A Capsule capable of resisting toxicity of radiotherapy and chemotherapy and manufacture process thereof |
| 04/20/2011 | CN102018950A Drug for treating hyperlipidemia, hyperviscosity, hypertension and coronary heart diseases |
| 04/20/2011 | CN102018949A Traditional Chinese medicine composition for treating vertigo |
| 04/20/2011 | CN102018948A Chinese medicinal composition for treating irregular menstruation |
| 04/20/2011 | CN102018945A 治疗脱肛的中药 Chinese medicine treatment of rectal prolapse |
| 04/20/2011 | CN102018942A Smoking cessation sober-up tea |
| 04/20/2011 | CN102018938A Traditional Chinese medicine prescription for treating cholelithiasis |
| 04/20/2011 | CN102018937A Medicament for treating acne and preparation method thereof |
| 04/20/2011 | CN102018936A Umbilically applied drug for treating gynaopathy and preparation method thereof |
| 04/20/2011 | CN102018933A Medicine for treating prosopalgia |
| 04/20/2011 | CN102018932A Medicament for treating epilepsy |
| 04/20/2011 | CN102018930A Medicine composition for treating hepatitis B |
| 04/20/2011 | CN102018928A Method for preparing traditional Chinese medicine for treating hypothyroidism |
| 04/20/2011 | CN102018925A Compound preparation for treating arthritis |
| 04/20/2011 | CN102018923A Chinese herbal medicine energy health promotion technology |
| 04/20/2011 | CN102018922A External drug for psoriasis |
| 04/20/2011 | CN102018921A Chinese medicine formula capable of treating asthma |
| 04/20/2011 | CN102018919A Gynecological inflammation pruritus eliminating suppository and preparation method thereof |
| 04/20/2011 | CN102018917A Traditional Chinese medicine pill for treating various polypi |
| 04/20/2011 | CN102018914A Traditional Chinese medicinal composition used for curing arteriosclerosis |
| 04/20/2011 | CN102018913A Medicament for treating neurosis |
| 04/20/2011 | CN102018910A Chinese medicinal preparation for treating septicemia |
| 04/20/2011 | CN102018906A Traditional Chinese medicinal formula for curing wind heat-type cold |